Buy-and-build is a term that gets used casually. In private equity and corporate development circles, it usually refers to a simple idea: acquire a strong platform company, then grow it through a series of add-on acquisitions rather than relying on organic growth alone. At that level, the concept sounds straightforward — almost obvious.
In practice, buy-and-build is neither simple nor obvious, and the reason many strategies struggle has less to do with deal quality than with a misunderstanding of what buy-and-build actually is.
Buy-and-build is more than growth by acquisition
At first glance, buy-and-build looks like an alternative growth engine. Companies accelerate growth by acquiring businesses that already exist instead of expanding slowly through new products, customers, or geographies. The appeal is clear: faster scale, broader capabilities, and the potential to create value through integration.
Consulting frameworks explain the economic logic well, academic research has studied the conditions under which buy-and-build outperforms other strategies, and experienced investors and operators apply these ideas every day. All of that work matters. What it doesn’t always capture is how buy-and-build behaves once it moves from concept to operating reality.
From the inside, buy-and-build feels different
Inside an operating company, buy-and-build feels less like a growth plan being executed and more like an organisation gradually taking on weight. Each acquisition adds more than revenue or capability. It adds:
• integration work that competes with day-to-day operations,
• leadership attention that has to be redirected,
• cultural differences that require negotiation rather than resolution,
• systems strain that often appears months after close, and
• decisions about sequencing that cannot be undone.
None of these challenges arrive all at once — they accumulate quietly. This is why many buy-and-build efforts don’t fail dramatically. They slow down. Execution becomes uneven, decision-making turns reactive, and performance drifts before anyone can point to a single mistake.
The constraint is rarely capital
One of the most persistent misconceptions about buy-and-build is that capital is the primary constraint. In practice, capital is often available well before the organisation is ready to absorb what that capital enables. The real constraints tend to be organisational: leadership bandwidth, integration capability, operating cadence, and the ability to learn from one deal before moving to the next.
When those limits are exceeded, adding another acquisition increases fragility rather than accelerating growth. This dynamic explains why two platforms pursuing similar strategies can produce very different outcomes. The difference is capacity — not ambition or intelligence.
Why sequencing changes everything
This is where buy-and-build begins to behave less like a strategy and more like a system. Early acquisitions matter disproportionately. They establish integration norms, expectations about pace, how much disruption is tolerated, and whether experience compounds into capability or dissipates into noise. Later acquisitions inherit the system that earlier ones created.
From this perspective, sequencing is a strategic choice about how much complexity the organisation takes on, and when — not a technical detail. Practitioners often recognise this intuitively. Deals that look attractive on paper are sometimes deferred, not because they don’t fit, but because the organisation isn’t ready yet. The question becomes “what will this do to the system we’re already carrying?” rather than “is this a good company?”
Buy-and-build as a system under load
Viewed this way, buy-and-build is best understood as a system operating under increasing load. Each acquisition changes the conditions under which the next one will occur. Leadership attention shifts, integration capacity stretches, and optionality narrows or expands depending on how well complexity is absorbed.
This is why buy-and-build can’t be reduced to a checklist or a formula. Its outcomes emerge over time, shaped by interaction effects that are difficult to see at the outset. Understanding those interactions is the real strategic work.
What this section will explore
The purpose of this Buy & Build Strategy section is to examine these dynamics deliberately, complementing existing frameworks by staying with operating reality a bit longer — where strategy meets capacity, sequencing, and leadership constraints. Over time, the section will return to questions like:
• how platforms create or lose expandability,
• how adjacency and distance affect integration risk,
• why sequencing matters more than deal volume, and
• how learning either compounds or breaks down across acquisitions.
Many practitioners already manage buy-and-build with these considerations in mind. The aim here is to give that intuition clearer language and to explore where it holds, and where it begins to strain.
Buy-and-build is about building organisations that can survive the deals you choose to do, more than it’s about doing more deals.
Why I’m writing this
I’m documenting what I’ve learned as an operator and what I’m uncovering through doctoral research into buy-and-build strategy, target selection, sequencing, and integration. The work will evolve and get challenged over time, and all of it stays grounded in operating reality.
If you’re a PE operator, builder, founder, searcher, or investor thinking seriously about acquisitions, I hope these field notes help you see buy-and-build more clearly. This piece sets the foundation; the rest of The Industrialist builds on it.
— Dave